Genosaber (格诺思博) Company Profile: Funding, Investors & Partnerships

Genosaber (格诺思博)

Genosaber, focuses on development, manufacture, sale and technical support of tumor diagnostic products. The core technology, CTC (circulating-tumor-cell) based IVD (in vitro diagnostic) targeting on Lung cancer, is one of the most promising techniques in IVD. Genosaber has received CFDA approval in 2015, which is the first CTC product been approved.Genosaber, focuses on development, manufacture, sale and technical support of tumor diagnostic produ Show More

Alpha Score

N/A